GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Map1lc3b | decreases expression | ISO | MAP1LC3B (Homo sapiens) | 6480464 | CTD | Ivermectin results in decreased expression of MAP1LC3B protein | PMID:32959892 | Map1lc3b | multiple interactions | ISO | MAP1LC3B (Homo sapiens) | 6480464 | CTD | 3-methyladenine inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein]; AZD 1480 inhibits the reaction [SLC2A4 protein inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein]]; Glutathione inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein]; Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein; SLC2A4 protein inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein] | PMID:34904774 | |
Go Back to source page | Continue to Ontology report |